In addition, the statistical analysis of the percentage change of the number of ΤΝΒC cells in phases “viable” and “apoptotic,” 24 hours after the administration of different concentrations of dasatinib, resulted in a highly significant (p=0.007<0.05) difference of percentage of TNBC cells between the “viable” and “apoptotic” cell categories, 24 hours after the administration of different concentrations of dasatinib.
← all excerpts
In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study.
1
—
—